Brickroad
Brickroad
IndexSignalsBlog
/Index//

Product

  • Information Frontier Agent
  • Vendor Management Agent
  • Product tour
  • Pricing

Solutions

  • Utility estimation
  • Context assembly
  • Market intelligence

Suppliers

  • Sell your data
  • Start onboarding
  • Programmatic Data License

Community

  • Public index
  • Signals
  • Blog

Company

  • About
  • Team
  • Careers
  • Brand

Connect

  • LinkedIn
  • X
PrivacyTermsCookies

© 2026 Brickroad

/Index/Approve Suite/Approve Suite
AS

Approve Suite

APPROVE SUITEManage supplier listing

A continuously refreshed, machine-readable regulatory-event stream built over eight public U.S. sources (FDA warning letters, FDA inspection classifications, openFDA recalls, Federal Register, eCFR Title 21, ClinicalTrials.gov, Drugs@FDA approvals and complete response letters, SEC EDGAR 8-K disclosures), where each raw record is re-published as a normalised event carrying a written summary, a 'why it matters' explanation, the CFR sections cited, a GxP-area tag, a severity tier, and a resolved company/indication/product-type identity — plus company profiles that fuse the FDA record with trial and financial data.

Open buyer room →
Approve Suite/Approve Suite
SampleCoverage

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Approve Suite and files the sample in your catalog — private to you.

Start 7-day trial→Nothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry
BiotechnologyPharmaceuticalsResearch & Consulting Services
Instruments
equities
Categories
AlternativeSentimentReference
Regions
US
Sample tickers
MRNABNTXVKTXNTLACRSPRLAYIBIO
Dataset card
Type
not stated
Format
Multimodal, machine-first: typed JSON event records served over a bearer-token REST API with a published OpenAPI schema and an MCP endpoint, each record pairing structured fields (event type, severity, GxP area, modality, stage, company, CFR references) with generated prose summaries and links back to the source documents.
Volume
Eight source feeds ingested continuously — inspections and approvals refreshed daily, the rest every two to six hours — annotated one record at a time with a summary, a relevance explanation and CFR/GxP tags. FDA publishes warning letters in the low hundreds per year, inspection classifications in the thousands, recalls in the tens of thousands, Title 21 Federal Register items and section-level eCFR amendments in the thousands, trial registration and status changes in the tens of thousands, approvals and complete response letters in the hundreds, and matching 8-K disclosures in the low thousands — so the annotated archive is plausibly in the high hundreds of thousands of enriched event records at a few hundred tokens of generated annotation each.
Users
Request further research — the operator publishes no registration or customer count. On the basis that it is a self-serve SaaS with a free tier, a single paid tier at 79 dollars a month, Stripe billing and no sales team or named staff, the registered-account base is plausibly in the low thousands of individual QA/RA practitioners, and no enterprise deployment is advertised.
History
not stated
Update frequency
not stated
Growth
Active — ingestion is continuous, with inspections and approvals updated daily and the remaining six sources every two to six hours.
Launched
Request further research — no launch, founding or first-publication date appears on the site, FAQ or terms. The developer documentation and its API examples are dated in 2026, which places the launch in the recent window, but the exact year needs confirming with the operator or an earliest archive snapshot.
Delivery
not stated
Entity mapping
not stated
Sample
not stated
Point-in-time
not stated
Licence
not stated

supplier index read from their site

Approve Suite has not added their own details yet. Not yet on file:

  • Dataset
  • Data dictionary
  • Coverage
  • Provenance
  • Rights & data handling